{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:21:57Z","timestamp":1769725317855,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,12,12]],"date-time":"2009-12-12T00:00:00Z","timestamp":1260576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00296-009-1269-9","type":"journal-article","created":{"date-parts":[[2009,12,11]],"date-time":"2009-12-11T14:06:42Z","timestamp":1260540402000},"page":"719-723","source":"Crossref","is-referenced-by-count":29,"title":["Osteonecrosis secondary to antiphospholipid syndrome: a case report, review of the literature, and treatment strategy"],"prefix":"10.1007","volume":"30","author":[{"given":"Waqar","family":"Haque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin","family":"Kadikoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Pacha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Maliakkal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vu","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,12]]},"reference":[{"key":"1269_CR1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/archinte.1978.03630290052018","volume":"138","author":"M Abeles","year":"1978","unstructured":"Abeles M, Urman JD, Rothfield N (1978) Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy. Arch Intern Med 138:750\u2013754","journal-title":"Arch Intern Med"},{"key":"1269_CR2","first-page":"136","volume":"5","author":"J Dimant","year":"1978","unstructured":"Dimant J, Ginzler EM, Diamond HS et al (1978) Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE. J Rheumatol 5:136\u2013141","journal-title":"J Rheumatol"},{"key":"1269_CR3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295\u2013306","journal-title":"J Thromb Haemost"},{"key":"1269_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12016-007-0006-y","volume":"32","author":"A Gorshtein","year":"2007","unstructured":"Gorshtein A, Levy Y (2007) Orthopedic involvement in antiphospholipid syndrome. Clin Rev Allergy Immunol 32:167\u2013171","journal-title":"Clin Rev Allergy Immunol"},{"key":"1269_CR5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/rheumatology\/keh481","volume":"44","author":"S Agarwala","year":"2005","unstructured":"Agarwala S et al (2005) Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. Rheumatology 44:352\u2013359","journal-title":"Rheumatology"},{"key":"1269_CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","volume":"58","author":"CG Helmick","year":"2008","unstructured":"Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Arthritis Rheum 58:15\u201325","journal-title":"Arthritis Rheum"},{"key":"1269_CR7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi I et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295\u2013306","journal-title":"J Thromb Haemost"},{"key":"1269_CR8","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0889-8588(18)30275-2","volume":"6","author":"RL Bick","year":"1992","unstructured":"Bick RL, Baker WF (1992) Anticardiolipin antibodies and thrombosis. Hematol Oncol Clin North Am 6:1287\u20131299","journal-title":"Hematol Oncol Clin North Am"},{"key":"1269_CR9","first-page":"78","volume":"117","author":"DA Triplett","year":"1993","unstructured":"Triplett DA (1993) Antiphospholipid antibodies and thrombosis: a consequence, coincidence, or cause? Arch Pathol Lab Med 117:78\u201388","journal-title":"Arch Pathol Lab Med"},{"key":"1269_CR10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0025-7125(16)30152-3","volume":"78","author":"RL Bick","year":"1994","unstructured":"Bick RL, Baker WF (1994) The antiphospholipid and thrombosis syndromes. Med Clin North Am 78:667\u2013684","journal-title":"Med Clin North Am"},{"key":"1269_CR11","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005792-198911000-00004","volume":"68","author":"RA Asherson","year":"1989","unstructured":"Asherson RA, Khamashta MA, Ordi-Ros J et al (1989) The \u201cprimary\u201d antiphospholipid syndrome: major clinical and serological features. Medicine 68:366\u2013374","journal-title":"Medicine"},{"key":"1269_CR12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/ard.48.8.672","volume":"48","author":"K Nagasawa","year":"1989","unstructured":"Nagasawa K, Ishii Y, Mayumi T et al (1989) Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis 48:672\u2013676","journal-title":"Ann Rheum Dis"},{"key":"1269_CR13","first-page":"297","volume":"8","author":"J Alijotas","year":"1990","unstructured":"Alijotas J, Argemi M, Barquinero J (1990) Kienbock\u2019s disease and antiphospholipid antibodies. Clin Exp Rheumatol 8:297\u2013298","journal-title":"Clin Exp Rheumatol"},{"key":"1269_CR14","first-page":"1416","volume":"18","author":"MJ Seleznick","year":"1991","unstructured":"Seleznick MJ, Silveira LH, Espinoza LR (1991) Avascular necrosis associated with anticardiolipin antibodies. J Rheumatol 18:1416\u20131417","journal-title":"J Rheumatol"},{"key":"1269_CR15","first-page":"545","volume":"9","author":"P Vela","year":"1991","unstructured":"Vela P, Batlle E, Salas E, Marco P (1991) Primary antiphospholipid syndrome and osteonecrosis (letter). Clin Exp Rheumatol 9:545\u2013546","journal-title":"Clin Exp Rheumatol"},{"key":"1269_CR16","first-page":"284","volume":"20","author":"RA Asherson","year":"1993","unstructured":"Asherson RA, Liote F, Page B et al (1993) Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 20:284\u2013288","journal-title":"J Rheumatol"},{"key":"1269_CR17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/096120339400300108","volume":"3","author":"S Migliaresi","year":"1994","unstructured":"Migliaresi S, Picillo U, Ambrosone L, Di Plama G et al (1994) Avascular necrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus 3:37\u201341","journal-title":"Lupus"},{"key":"1269_CR18","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood.V81.10.2618.2618","volume":"83","author":"JD Oosting","year":"1993","unstructured":"Oosting JD, Derksen RHWM, Bobbink IWG et al (1993) Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: an explanation for their pathogenic mechanism? Blood 83:2618\u20132625","journal-title":"Blood"},{"key":"1269_CR19","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1182\/blood.V74.7.2426.2426","volume":"74","author":"E Marciniak","year":"1989","unstructured":"Marciniak E, Romond EH (1989) Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant. Blood 74:2426\u20132432","journal-title":"Blood"},{"key":"1269_CR20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.1990.tb07843.x","volume":"76","author":"RG Malia","year":"1990","unstructured":"Malia RG, Kitchen S, Greaves M, Preston FE (1990) Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 76:101\u2013107","journal-title":"Br J Haematol"},{"key":"1269_CR21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1529-0131(199901)42:1<167::AID-ANR20>3.0.CO;2-B","volume":"42","author":"M Ieko","year":"1999","unstructured":"Ieko M, Ichikawa K, Triplett DA (1999) \u03b22-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies. Arthritis Rheum 42:167\u2013174","journal-title":"Arthritis Rheum"},{"key":"1269_CR22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.ATV.12.2.196","volume":"12","author":"G Escolar","year":"1992","unstructured":"Escolar G, Font J, Reverter JC (1992) Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet aggregation. Arterioscler Thromb 12:196\u2013200","journal-title":"Arterioscler Thromb"},{"key":"1269_CR23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-0038-1642734","volume":"73","author":"AL Campbell","year":"1995","unstructured":"Campbell AL, Pierangeli SS, Wellhausen S, Harris EN (1995) Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation. Thromb Haemost 73:529\u2013534","journal-title":"Thromb Haemost"},{"key":"1269_CR24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/ard.47.10.849","volume":"47","author":"MA Khamashta","year":"1988","unstructured":"Khamashta MA, Harris EN, Gharavi AE (1988) Immune mediated mechanism for thrombosis:antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 47:849\u2013854","journal-title":"Ann Rheum Dis"},{"key":"1269_CR25","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.4049\/jimmunol.153.3.1328","volume":"153","author":"A Kornberg","year":"1994","unstructured":"Kornberg A, Blank M, Kaufman S, Shoenfeld Y (1994) Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol 153:1328\u20131332","journal-title":"J Immunol"},{"key":"1269_CR26","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1172\/JCI118276","volume":"96","author":"R Simantov","year":"1995","unstructured":"Simantov R, LaSala JM, Lo SK (1995) Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 96:2211\u20132219","journal-title":"J Clin Invest"},{"key":"1269_CR27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780400322","volume":"40","author":"N Del Papa","year":"1997","unstructured":"Del Papa N, Guidali L, Sala A (1997) Endothelial cells as target for antiphospholipid antibodies\u2014human polyclonal and monoclonal anti-\u03b22 glycoprotein I antibodies react in vitro with endothelial cells through adherent \u03b22 glycoprotein I and induce endothelial activation. Arthritis Rheum 40:551\u2013561","journal-title":"Arthritis Rheum"},{"key":"1269_CR28","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/art.1780400509","volume":"40","author":"MJ Cuadrado","year":"1997","unstructured":"Cuadrado MJ, L\u00f3pez-Pedrera C, Khamashta MA (1997) Thrombosis in primary antiphospholipid syndrome\u2014a pivotal role for monocyte tissue factor expression. Arthritis Rheum 40:834\u2013841","journal-title":"Arthritis Rheum"},{"key":"1269_CR29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-0037-1614977","volume":"79","author":"O Amengual","year":"1998","unstructured":"Amengual O, Atsumi T, Khamashta MA, Hughes GRV (1998) The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost 79:276\u2013281","journal-title":"Thromb Haemost"},{"key":"1269_CR30","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.21009","volume":"52","author":"M Vega-Ostertag","year":"2005","unstructured":"Vega-Ostertag M, Casper K, Swerlick R et al (2005) Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum 52:1545\u20131554","journal-title":"Arthritis Rheum"},{"key":"1269_CR31","first-page":"783","volume":"30","author":"LC Jones","year":"2003","unstructured":"Jones LC, Mont MA, Le TB et al (2003) Procoagulants and osteonecrosis. J Rheumatol 30:783\u2013791","journal-title":"J Rheumatol"},{"key":"1269_CR32","first-page":"466","volume":"34","author":"MA Mont","year":"2007","unstructured":"Mont MA, Ulrich SD, Seyler TM (2007) Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis. J Rheumatol 34:466\u2013468","journal-title":"J Rheumatol"},{"key":"1269_CR33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajh.2830450212","volume":"45","author":"CJ Glueck","year":"1994","unstructured":"Glueck CJ, Freiberg R, Glueck HI et al (1994) Hypofibrinolysis: a common, major cause of osteonecrosis. Am J Hematol 45:156\u2013166","journal-title":"Am J Hematol"},{"key":"1269_CR34","first-page":"319","volume":"125","author":"CJ Glueck","year":"1995","unstructured":"Glueck CJ, Rorick MH, Schmerler M et al (1995) Hypofibrinolytic and atherogenic risk factors for stroke. J Lab Clin Med 125:319\u2013325","journal-title":"J Lab Clin Med"},{"key":"1269_CR35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1203\/00006450-199404000-00001","volume":"35","author":"CJ Glueck","year":"1994","unstructured":"Glueck CJ, Glueck HI, Greenfield D et al (1994) Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease. Pediatr Res 35:383\u2013388","journal-title":"Pediatr Res"},{"key":"1269_CR36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0022-2143(96)90065-7","volume":"127","author":"R Gruppo","year":"1996","unstructured":"Gruppo R, Glueck CJ, McMahon RE, Bouquot J, Rabinovich BA, Becker A, Tracy T, Wang P (1996) The pathophysiology of alveolar osteonecrosis of the jaw: anticardiolipin antibodies, thrombophilia, and hypofibrinolysis. J Lab Clin Med 127:481\u2013488","journal-title":"J Lab Clin Med"},{"key":"1269_CR37","first-page":"654","volume":"24","author":"MA Mont","year":"1997","unstructured":"Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M (1997) Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 24:654\u2013662","journal-title":"J Rheumatol"},{"key":"1269_CR38","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1309\/RLNM-J01W-BJRN-LH03","volume":"125","author":"K Darabi","year":"2006","unstructured":"Darabi K, Berg AH (2006) Rituximab can be combined with daily plasma exchange to achieve effective B-cell depletion and clinical improvement in acute autoimmune TTP. Am J Clin Path 125:592\u2013597","journal-title":"Am J Clin Path"},{"key":"1269_CR39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2141.2003.04049.x","volume":"120","author":"S Allford","year":"2003","unstructured":"Allford S, Machin S (2003) Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 120:556\u2013573","journal-title":"Br J Haematol"},{"key":"1269_CR40","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2169\/internalmedicine.41.725","volume":"41","author":"S Otsubo","year":"2002","unstructured":"Otsubo S, Nitta K, Yumura W, Nihei H, Mori N (2002) Antiphospholipid syndrome treated with prednisolone, cyclophosphamide and double-filtration plasmapheresis. Intern Med 41:725\u2013729","journal-title":"Intern Med"},{"key":"1269_CR41","unstructured":"Aaron RK (1998) Osteonecrosis: etiology, pathophysiology, and diagnosis. The adult hip, Lippincott-Raven Publishers, Philadelphia, pp 451\u2013466"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1269-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-009-1269-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1269-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T21:32:54Z","timestamp":1685223174000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-009-1269-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["1269"],"URL":"https:\/\/doi.org\/10.1007\/s00296-009-1269-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,12]]}}}